Drilldown: Medicines

None · Codeine · 1,4-Butanediol · 1B-LSD · 1cP-LSD · 1P-LSD · 1V-LSD · 2-AI · 2-FA · 2-FDCK · 2-FMA · 25B-NBOH · 25B-NBOMe · 25C-NBOH · 25C-NBOMe · 25I-NBOH · 25I-NBOMe · 25N-NBOMe · 2C-B · 2C-B-FLY

Other values:

Search

Nexus, Eroxan (historical, late-1980s through mid-1990s) (1) · Trandate, Normodyne (discontinued in US) (1)

2C-x series (1) · Phenethylamine (1) · Psychedelic (1) · [[:Category:Antihypertensives|Antihypertensive]] (1) · [[:Category:Beta blockers|Combined alpha-1 and non-selective beta blocker]] (1)

5-HT2A partial agonist (1) · '"`UNIQ--vote-00000015-QINU`"' The favorable pregnancy safety profile and the dual mechanism support its first-line role in pregnancy-associated hypertension and in hypertensive emergencies where rapid, controllable BP reduction is needed'"`UNIQ--ref-00000016-QINU`"'. (1)

None (1) · '"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"' (1)

None (1) · Oral: 100 mg PO BID, titrate to 400 mg BID. IV: 20 mg over 2 minutes, repeat 40-80 mg every 10 minutes as needed (maximum cumulative 300 mg); continuous infusion 2 mg/minute (1)

None (1) · Tablets 100, 200, 300 mg; injection 5 mg/mL (1)

None (1) · 2400 mg/day (oral); 300 mg total per IV bolus dosing series (1)

insufflated (1) · intravenous (1) · Oral (2) · PR (1)

45-75 min (oral) (1) · BP effect within hours (oral); 5-10 minutes (IV) (1)

4-8 h (1) · 8-12 hours (oral); 4-6 hours (IV) (1)

Not well characterized (1) · ~6-8 hours'"`UNIQ--ref-0000001A-QINU`"' (1)

Not well characterized (1) · ~25% (oral; extensive first-pass)'"`UNIQ--ref-0000001B-QINU`"' (1)

'''Among the safest antihypertensives in pregnancy''', recommended for chronic hypertension during pregnancy and first-line for severe hypertension in preeclampsia and eclampsia'"`UNIQ--ref-0000001C-QINU`"' (1) · Not established (1)

[[USLegal:DEA Schedule I|Schedule I]] (United States) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)